Is. Kaskarelis et al., PERCUTANEOUS METALLIC SELF-EXPANDABLE ENDOPROSTHESES IN BILIARY OBSTRUCTION CAUSED BY METASTATIC CANCER, Hepato-gastroenterology, 43(10), 1996, pp. 785-791
Background/Aims: Up to now, all reports about metallic stents concerne
d mostly patients with obstructive jaundice due to primary cancer alth
ough some of these series included a smalt number of patients with met
astatic disease as a cause of occlusion of the bile ducts. The questio
n of whether they should be used in patients with biliary obstruction
due to metastatic disease, and consequently have a limited life expect
ancy, is investigated. Patients And Methods; Between January 1994 and
April 1995, we inserted percutaneously 20 metallic self-expandable end
oprostheses in. 14 patients with obstructive jaundice due to metastati
c disease. Results: Twelve patients died with a mean survival of 144.6
(range 25 - 338) days without arty evidence of biliary reobstruction.
For 2 patients, we have follow-up no Longer than. 30 days. Thirty day
mortality was 7.2% (1/14). Jaundice reoccurred in one patient but was
n't related to stent obstruction, and he died during the first 30 days
. We had 2 cases with moderate hemobilia. Conclusion: We believe that
the use of metal stents in patients with obstructive jaundice due to m
etastatic disease is justified. Their high initial cost is offset by t
heir prolong patency, decreased complication, rate and shorter hospita
lization.